Rush to PCSK9 Inhibitor Pretreatment Disappoints in Acute MI Trial

(MedPage Today) -- Heart attack patients gained faster control of LDL cholesterol starting PCSK9 inhibitor therapy immediately in the cath lab, the AMUNDSEN trial showed, while a clinical benefit could not be proven. High-risk patients with acute...